id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-3758-0009,FDA,FDA-2018-N-3758,"Agency Information Collection
Activities; Proposed Collection;
Comment Request; Expanded Access
to Investigational Drugs for Treatment
Use",Notice,60 Day Proposed Information Collection,2021-12-14T05:00:00Z,2021,12,2021-12-14T05:00:00Z,2022-02-15T04:59:59Z,2023-04-27T14:49:59Z,2021-26990,0,0,0900006484ec65df
FDA-2018-N-3758-0008,FDA,FDA-2018-N-3758,"INSTRUCTIONS FOR FILLING OUT FORM FDA 3926 – INDIVIDUAL PATIENT EXPANDED
ACCESS, INVESTIGATIONAL NEW DRUG APPLICATION (IND)",Other,Forms,2021-12-02T05:00:00Z,2021,12,2021-12-02T05:00:00Z,,2021-12-02T16:14:24Z,,0,0,0900006484e95bb3
FDA-2018-N-3758-0007,FDA,FDA-2018-N-3758,"INDIVIDUAL PATIENT EXPANDED ACCESS, INVESTIGATIONAL NEW DRUG APPLICATION (IND)",Other,Forms,2021-12-02T05:00:00Z,2021,12,2021-12-02T05:00:00Z,,2021-12-02T16:13:06Z,,0,0,0900006484e95bb1